Intel Plans $15 Billion Stock Sale to Fund Foundry Expansion as Shares Fall

Intel is turning one of the strongest rallies in its recent history into fresh capital, announcing plans to raise $15 billion through a common-stock offering as it commits more money to chip manufacturing, advanced packaging and the next stage of its foundry expansion.

The offering is unusually large even for a company of Intel’s scale. Underwriters will also have a 30-day option to purchase as much as $2.25 billion of additional stock, which could push the total amount sold to $17.25 billion if the option is exercised in full. JPMorgan Securities, Goldman Sachs, Morgan Stanley and Citigroup are acting as joint book-running managers.

Intel said the proceeds will be available for general corporate purposes, including capital expenditures and working capital. The company has been raising its spending plans as demand tied to artificial intelligence increases the need for data-center processors, semiconductor manufacturing capacity and advanced packaging.

Investors focused immediately on the dilution that comes with issuing such a large amount of new equity. Intel shares fell roughly 4% after the announcement Monday, even after a powerful run that has left the stock far above where it began the year.

That rally is an important part of why Intel can raise this much capital now.

The stock had nearly tripled in 2026 before Monday’s offering announcement, according to Reuters, giving Intel a dramatically stronger currency for raising equity than it had during the more difficult stages of its turnaround. Selling shares after a large appreciation means the company can raise the same amount of cash while issuing fewer shares than it would have needed at a much lower valuation.

For existing shareholders, the tradeoff is straightforward. The offering strengthens Intel’s financial resources at a time when it wants to invest aggressively, but it also increases the number of shares among which future earnings will be divided.

Intel’s spending plans have risen with AI demand

The equity raise follows a sharp improvement in Intel’s operating momentum.

Intel reported second-quarter revenue of $16.1 billion, up 25% from a year earlier and its strongest revenue growth in more than 15 years. The company forecast third-quarter revenue of $15.8 billion to $16.8 billion and non-GAAP earnings of 38 cents a share.

The quarter was particularly important because Intel’s growth is increasingly being tied to AI even though the company does not dominate the market for AI accelerators in the way Nvidia does.

Instead, Intel is benefiting from another part of the AI buildout. Large AI systems need far more than GPUs. Data centers also require CPUs to manage workloads and feed accelerators, custom chips for specialized tasks, networking, wafer manufacturing and increasingly sophisticated packaging that combines different types of silicon into a single system.

Intel CEO Lip-Bu Tan has said the move from large foundational AI models toward inference and autonomous AI agents is increasing demand for Intel CPUs as well as its wafer-manufacturing and advanced-packaging capabilities. Intel made that case as early as its first-quarter results, when it said the next wave of AI was increasing demand across those parts of the company.

By the second quarter, demand was strong enough for Intel to raise its 2026 capital expenditure forecast from $18 billion to $20 billion. The company also indicated that spending would rise further in 2027.

That changes the financial question facing Intel. For several years, much of the company’s turnaround was about controlling costs, restructuring operations and avoiding investments that were not supported by clear customer demand. Now Intel is seeing stronger demand while simultaneously trying to fund an expensive manufacturing roadmap. The $15 billion offering gives management considerably more room to pursue both.

The company has already been increasing capacity in areas where AI demand is particularly visible. Earlier this year, Intel Foundry expanded assembly and testing operations in Penang, Malaysia, citing rising global demand for packaging solutions.

In July, Intel announced another €5 billion investment in Ireland to expand leading-edge manufacturing capacity. That single project is equivalent to more than one-quarter of Intel’s newly raised 2026 capital-spending forecast.

Advanced packaging is becoming especially important as AI systems move away from relying on one monolithic processor and increasingly combine CPUs, accelerators, memory and specialized chiplets. Intel has continued investing in technologies such as EMIB and Foveros, which allow multiple pieces of silicon to be integrated into complex packages. Its annual filing describes advanced packaging as a central part of both its internal product strategy and its effort to attract external foundry customers.

The foundry strategy still carries a much bigger financial test

The offering is not simply about satisfying near-term CPU demand. Intel is also trying to prove that it can become a major contract manufacturer of advanced chips for other companies, bringing it into more direct competition with Taiwan Semiconductor Manufacturing Co.

That ambition is enormously capital intensive. A leading-edge semiconductor foundry must spend billions of dollars on fabrication plants, lithography equipment, clean rooms and process development before customer revenue arrives. It also needs enough manufacturing volume to spread those fixed costs across a large number of wafers.

Intel has acknowledged that problem directly. In its 2025 annual filing, the company said the economics of next-generation manufacturing require wafer volumes beyond what it expects from Intel’s own products alone. Intel therefore needs meaningful external foundry customers if it is going to justify continued investment in the most advanced process technologies.

That issue is particularly important for Intel 14A, the process generation that follows Intel 18A and Intel 18A-P.

Intel has said it is continuing to develop 14A and now has several future Intel products designed to use the technology. But the company has also warned that if it cannot secure sufficient committed demand from major outside customers, developing and manufacturing 14A and its successors may not be economically viable. In that scenario, Intel has said it could pause or discontinue those process technologies and rely more heavily on external foundries for future leading-edge products.

That makes the current capital raise unusually consequential. The $15 billion gives Intel more ability to fund manufacturing, but it does not remove the need to prove that the new capacity will ultimately generate acceptable returns. The success of the foundry strategy still depends on process execution, yields and, most importantly, winning enough external customers to fill the factories.

Intel has nevertheless been showing signs of progress. The company is already producing its own products using Intel 18A, and it has continued developing 18A-P for future Intel products and outside foundry customers. Intel has also previously announced a multiyear, multibillion-dollar manufacturing framework with Amazon Web Services that includes an AI fabric chip on Intel 18A and engagement across Intel 18A, 18A-P and 14A.

Reuters reported that Intel’s foundry business has attracted additional customer interest as AI companies look for more manufacturing capacity and alternative sources of advanced chips.

Still, foundry expansion has to be considered against Intel’s financial history. The business has consumed large amounts of capital while the company has tried to restore process leadership and compete against TSMC, which operates at much greater external foundry scale.

That is why raising equity rather than relying entirely on additional debt has strategic value.

Intel has already tapped several sources of outside capital

The $15 billion stock sale is the latest in a series of moves that have reshaped Intel’s balance sheet and shareholder base.

In August 2025, SoftBank agreed to invest $2 billion in Intel by purchasing approximately 87 million newly issued shares at $23 apiece.

Days later, Intel reached a much larger agreement with the U.S. government. Under that transaction, previously committed CHIPS Act and Secure Enclave funding was converted into an $8.9 billion investment in Intel common stock, giving the federal government a roughly 9.9% stake based on the terms announced at the time.

Intel also raised debt earlier this year. In April, the company issued $6.5 billion of senior notes across maturities running from 2031 through 2066. The proceeds were used in connection with Intel’s repurchase of the minority interest in the entity associated with its Fab 34 manufacturing operation in Ireland.

The new common-stock offering therefore gives Intel another source of capital without adding another $15 billion of borrowing to its balance sheet.

That matters because semiconductor manufacturing investments take years to earn back their cost. New factories and process technologies can require billions in spending long before they reach full production, and Intel is simultaneously investing in 18A, future 14A manufacturing, advanced packaging and expanded capacity in multiple countries.

Using equity reduces the additional interest expense and refinancing risk that would come with funding the entire expansion through debt. The cost instead falls on shareholders through dilution.

Intel’s past capital allocation makes the contrast particularly striking. The company spent roughly $82 billion buying back its own shares during the 2010s, according to Reuters. It is now issuing a large block of new stock to help finance the manufacturing investments at the center of its turnaround.

The comparison does not mean the earlier repurchases directly caused the current offering. Intel’s competitive position, semiconductor manufacturing needs and the scale of AI investment have changed substantially since then. But it illustrates how dramatically the company’s capital priorities have shifted from returning cash to shareholders toward rebuilding manufacturing capacity.

The offering is a bet that Intel’s turnaround can justify the dilution

The market’s initial reaction reflects a tension that will remain after the stock sale is completed.

Intel’s underlying business is improving. Revenue growth has accelerated, AI-related CPU demand has strengthened, manufacturing yields and cycle times have improved, and management has enough confidence in demand to raise spending rather than cut it.

At the same time, the company is asking shareholders to absorb a substantial new equity issuance to finance that opportunity.

Investors will ultimately judge the offering less by the immediate dilution than by what Intel earns on the capital it raises.

If higher spending helps Intel convert AI demand into sustained CPU sales, advanced-packaging revenue and meaningful external foundry business, the additional capital could strengthen the turnaround. If foundry utilization remains weak or next-generation processes fail to attract sufficient customers, Intel could end up with a larger share count alongside an expensive manufacturing footprint.

That distinction is especially important because Intel has spent the last year emphasizing that future capital investment will be tied more closely to customer commitments and economic returns rather than factory expansion for its own sake. Its regulatory filings repeatedly stress that leading-edge manufacturing investment must be justified by sufficient demand.

The current offering suggests management believes that demand is becoming strong enough to warrant another major step.

Intel’s second-quarter numbers support at least part of that case. Revenue increased 25% year over year to $16.1 billion, and the company’s third-quarter sales forecast exceeded the Wall Street consensus at the time of the earnings report. Its 2026 spending plan has risen to $20 billion, and management expects investment to increase again in 2027.

But the offering also raises the hurdle for the turnaround. More capital gives Intel greater capacity to invest, while more shares mean the eventual improvement in earnings must be spread across a larger shareholder base.

The final dilution will depend on the price at which the $15 billion offering is completed and whether underwriters exercise their option for an additional $2.25 billion of shares.

Sources

Reuters: Intel’s $15 billion offering, market reaction, capital spending and offering terms.

Intel Investor Relations: Intel’s 2026 AI-demand, manufacturing and advanced-packaging strategy.